Desplanches, Thomas
Marchand-Martin, Laetitia
Szczepanski, Emilie-Denise
Ruillier, Marie
Cottenet, Jonathan
Semama, Denis
Simon, Emmanuel
Quantin, Catherine
Sagot, Paul
Article History
Received: 24 August 2021
Accepted: 11 January 2022
First Online: 19 January 2022
Declarations
:
: The collection of data by Burgundy Perinatal Network was approved by the French Committee for Data Protection (Commission Nationale Informatique et Liberté - Authorization number 455451) and this study was conducted in accordance with the Declaration of Helsinki. The database was used in accordance with article 6–1-c (Lawfulness of processing) of the European General Data Protection Regulation. Consent to participate was not required by law due to the retrospective and non-interventional nature of the study (ExternalRef removed).Ethics committee approval was not required for this study because we solely reported on anonymized data from patient medical records. These data have been collected in accordance with our usual practices and patients underwent no supplementary procedures for this investigation. Upon admission, each patient at our institution receives a written document that specifically mentions the possibility that anonymized medical data collected during hospitalization could be used for medical research.
: Not applicable.
: Author Paul Sagot received funding from the following commercial companies: Merck Serono, Ferring, MSD France SAS, Teva Sante SAS, Gedeon Richter France, Effik S. A, and GE Medical Systems SCS. The author confirms that none of this funding was used to support the research in this study.The other authors report no conflict of interest.